Balyasny Asset Management LLC Pfizer Inc Transaction History

Balyasny Asset Management LLC

$54.9 Billion
Q2 2024

A detailed history of Balyasny Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 25,300 shares of PFE stock, worth $694,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,300

Previous 643,376 96.07%

Holding current value

$694,738

Previous $17.9 Million 96.04%

% of portfolio

0.0%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $147 Million - $172 Million	5,800,893 Added 901.63%	6,444,269 $180 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $44.7 Million - $51.3 Million	-1,726,673 Reduced 72.85%	643,376 $17.9 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $136 Million - $177 Million	-5,222,829 Reduced 68.79%	2,370,049 $68.2 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $228 Million - $267 Million	7,107,540 Added 1464.45%	7,592,878 $252 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $10.7 Million - $12.4 Million	296,988 Added 157.68%	485,338 $17.8 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $1.68 Million - $2.18 Million	-42,557 Reduced 18.43%	188,350 $7.68 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $5.64 Million - $7.36 Million	135,029 Added 140.83%	230,907 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $2.92 Million - $3.57 Million	66,750 Added 229.16%	95,878 $4.2 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $414,349 - $491,288	-8,905 Reduced 23.41%	29,128 $1.53 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $53.5 Million - $66.3 Million	-1,168,797 Reduced 96.85%	38,033 $1.97 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $44.1 Million - $65.4 Million	1,067,959 Added 769.03%	1,206,830 $71.3 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $52.4 Million - $67.3 Million	-1,335,552 Reduced 90.58%	138,871 $5.97 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $9.01 Million - $10.6 Million	283,664 Added 23.82%	1,474,423 $54.1 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $8.84 Million - $10.7 Million	-293,400 Reduced 19.77%	1,190,759 $38.9 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $40.1 Million - $57.3 Million	1,484,159 New	1,484,159 $48.4 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $186,362 - $241,657	-5,736 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $76.7 Million - $86.1 Million	-2,073,189 Reduced 99.72%	5,736 $248,000
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $77.7 Million - $85.4 Million	2,073,124 Added 35737.36%	2,078,925 $88.3 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $16.5 Million - $18.8 Million	-427,606 Reduced 98.66%	5,801 $253,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $12.4 Million - $15 Million	359,909 Added 489.69%	433,407 $19.1 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $1.72 Million - $1.84 Million	-52,260 Reduced 41.56%	73,498 $2.67 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $6.17 Million - $7.15 Million	-193,216 Reduced 60.57%	125,758 $4.46 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $7.28 Million - $7.73 Million	218,974 Added 218.97%	318,974 $11.6 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $3.1 Million - $3.42 Million	100,000	100,000 $3.57 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Pfizer Inc Transaction History